Cresco Labs (CL) Stock Overview
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
CL Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Cresco Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.74 |
| 52 Week High | CA$2.79 |
| 52 Week Low | CA$0.60 |
| Beta | 1.52 |
| 1 Month Change | -1.33% |
| 3 Month Change | -8.64% |
| 1 Year Change | -65.58% |
| 3 Year Change | -81.07% |
| 5 Year Change | -89.35% |
| Change since IPO | -88.70% |
Recent News & Updates
Cresco Labs Inc.'s (CSE:CL) 30% Share Price Plunge Could Signal Some Risk
Jun 15
Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up
May 01Recent updates
Cresco Labs Inc.'s (CSE:CL) 30% Share Price Plunge Could Signal Some Risk
Jun 15Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up
May 01
Expanding Production In Illinois, Pennsylvania And Kentucky Will Meet Demand
Expansion in Illinois and Pennsylvania and entry into Kentucky's market aim to boost revenue growth and market share.Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 27%
Mar 07Is Cresco Labs (CSE:CL) A Risky Investment?
Jan 31Cresco Labs Inc. (CSE:CL) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Dec 14Getting In Cheap On Cresco Labs Inc. (CSE:CL) Is Unlikely
Oct 24Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Aug 11Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 34%?
Jul 17Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden
Jun 19Cresco Labs Inc.'s (CSE:CL) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 19Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41
Mar 16Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%
Mar 03Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt
Jan 26Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)
Jan 04Is Cresco Labs (CSE:CL) Using Too Much Debt?
Sep 22Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%
Aug 11Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet
Jan 25Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?
Dec 13We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt
Aug 22Shareholder Returns
| CL | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 5.7% | 6.1% | 0.4% |
| 1Y | -65.6% | -47.9% | 19.9% |
Return vs Industry: CL underperformed the Canadian Pharmaceuticals industry which returned -52.3% over the past year.
Return vs Market: CL underperformed the Canadian Market which returned 19.3% over the past year.
Price Volatility
| CL volatility | |
|---|---|
| CL Average Weekly Movement | 13.2% |
| Pharmaceuticals Industry Average Movement | 12.7% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.5% |
Stable Share Price: CL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: CL's weekly volatility (13%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,900 | Charlie Bachtell | www.crescolabs.com |
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s Edibles brand, as well as licenses the Kiva brand.
Cresco Labs Inc. Fundamentals Summary
| CL fundamental statistics | |
|---|---|
| Market cap | CA$303.32m |
| Earnings (TTM) | -CA$114.50m |
| Revenue (TTM) | CA$954.21m |
Is CL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CL income statement (TTM) | |
|---|---|
| Revenue | US$697.32m |
| Cost of Revenue | US$354.93m |
| Gross Profit | US$342.38m |
| Other Expenses | US$426.06m |
| Earnings | -US$83.68m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 49.10% |
| Net Profit Margin | -12.00% |
| Debt/Equity Ratio | 103.5% |
How did CL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/08 13:17 |
| End of Day Share Price | 2025/07/08 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cresco Labs Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Capital Markets |
| Russell Stanley | Beacon Securities Limited |